Lung Cancer
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolle ... Read More
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lower GI Series Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Double-Contrast
1.2.3 Single-Contrast
1.3 Market by Application
1.3.1 Global Lower GI Series Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lower GI Series Market Perspective (2016-2027)
2.2 Lower GI Series Growth Trends by Regions
2.2.1 Lower GI Series Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lower GI Series Historic Market Share by Regions (2016-2021)
2.2.3 Lower GI Series Forecasted Market Size by Regions (2022-2027)
2.3 Lower GI Series Industry Dynamic
2.3.1 Lower GI Series Market Trends
2.3.2 Lower GI Series Market Drivers
2.3.3 Lower GI Series Market Challenges
2.3.4 Lower GI Series Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lower GI Series Players by Revenue
3.1.1 Global Top Lower GI Series Players by Revenue (2016-2021)
3.1.2 Global Lower GI Series Revenue Market Share by Players (2016-2021)
3.2 Global Lower GI Series Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lower GI Series Revenue
3.4 Global Lower GI Series Market Concentration Ratio
3.4.1 Global Lower GI Series Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lower GI Series Revenue in 2020
3.5 Lower GI Series Key Players Head office and Area Served
3.6 Key Players Lower GI Series Product Solution and Service
3.7 Date of Enter into Lower GI Series Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lower GI Series Breakdown Data by Type
4.1 Global Lower GI Series Historic Market Size by Type (2016-2021)
4.2 Global Lower GI Series Forecasted Market Size by Type (2022-2027)
5 Lower GI Series Breakdown Data by Application
5.1 Global Lower GI Series Historic Market Size by Application (2016-2021)
5.2 Global Lower GI Series Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lower GI Series Market Size (2016-2027)
6.2 North America Lower GI Series Market Size by Type
6.2.1 North America Lower GI Series Market Size by Type (2016-2021)
6.2.2 North America Lower GI Series Market Size by Type (2022-2027)
6.2.3 North America Lower GI Series Market Size by Type (2016-2027)
6.3 North America Lower GI Series Market Size by Application
6.3.1 North America Lower GI Series Market Size by Application (2016-2021)
6.3.2 North America Lower GI Series Market Size by Application (2022-2027)
6.3.3 North America Lower GI Series Market Size by Application (2016-2027)
6.4 North America Lower GI Series Market Size by Country
6.4.1 North America Lower GI Series Market Size by Country (2016-2021)
6.4.2 North America Lower GI Series Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Lower GI Series Market Size (2016-2027)
7.2 Europe Lower GI Series Market Size by Type
7.2.1 Europe Lower GI Series Market Size by Type (2016-2021)
7.2.2 Europe Lower GI Series Market Size by Type (2022-2027)
7.2.3 Europe Lower GI Series Market Size by Type (2016-2027)
7.3 Europe Lower GI Series Market Size by Application
7.3.1 Europe Lower GI Series Market Size by Application (2016-2021)
7.3.2 Europe Lower GI Series Market Size by Application (2022-2027)
7.3.3 Europe Lower GI Series Market Size by Application (2016-2027)
7.4 Europe Lower GI Series Market Size by Country
7.4.1 Europe Lower GI Series Market Size by Country (2016-2021)
7.4.2 Europe Lower GI Series Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lower GI Series Market Size (2016-2027)
8.2 Asia-Pacific Lower GI Series Market Size by Type
8.2.1 Asia-Pacific Lower GI Series Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lower GI Series Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lower GI Series Market Size by Type (2016-2027)
8.3 Asia-Pacific Lower GI Series Market Size by Application
8.3.1 Asia-Pacific Lower GI Series Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lower GI Series Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lower GI Series Market Size by Application (2016-2027)
8.4 Asia-Pacific Lower GI Series Market Size by Region
8.4.1 Asia-Pacific Lower GI Series Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lower GI Series Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lower GI Series Market Size (2016-2027)
9.2 Latin America Lower GI Series Market Size by Type
9.2.1 Latin America Lower GI Series Market Size by Type (2016-2021)
9.2.2 Latin America Lower GI Series Market Size by Type (2022-2027)
9.2.3 Latin America Lower GI Series Market Size by Type (2016-2027)
9.3 Latin America Lower GI Series Market Size by Application
9.3.1 Latin America Lower GI Series Market Size by Application (2016-2021)
9.3.2 Latin America Lower GI Series Market Size by Application (2022-2027)
9.3.3 Latin America Lower GI Series Market Size by Application (2016-2027)
9.4 Latin America Lower GI Series Market Size by Country
9.4.1 Latin America Lower GI Series Market Size by Country (2016-2021)
9.4.2 Latin America Lower GI Series Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lower GI Series Market Size (2016-2027)
10.2 Middle East & Africa Lower GI Series Market Size by Type
10.2.1 Middle East & Africa Lower GI Series Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lower GI Series Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lower GI Series Market Size by Type (2016-2027)
10.3 Middle East & Africa Lower GI Series Market Size by Application
10.3.1 Middle East & Africa Lower GI Series Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lower GI Series Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lower GI Series Market Size by Application (2016-2027)
10.4 Middle East & Africa Lower GI Series Market Size by Country
10.4.1 Middle East & Africa Lower GI Series Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lower GI Series Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eisai
11.1.1 Eisai Company Details
11.1.2 Eisai Business Overview
11.1.3 Eisai Lower GI Series Introduction
11.1.4 Eisai Revenue in Lower GI Series Business (2016-2021)
11.1.5 Eisai Recent Development
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Company Details
11.2.2 Cadila Pharmaceuticals Business Overview
11.2.3 Cadila Pharmaceuticals Lower GI Series Introduction
11.2.4 Cadila Pharmaceuticals Revenue in Lower GI Series Business (2016-2021)
11.2.5 Cadila Pharmaceuticals Recent Development
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Details
11.3.2 Purdue Pharma Business Overview
11.3.3 Purdue Pharma Lower GI Series Introduction
11.3.4 Purdue Pharma Revenue in Lower GI Series Business (2016-2021)
11.3.5 Purdue Pharma Recent Development
11.4 Peacehealth
11.4.1 Peacehealth Company Details
11.4.2 Peacehealth Business Overview
11.4.3 Peacehealth Lower GI Series Introduction
11.4.4 Peacehealth Revenue in Lower GI Series Business (2016-2021)
11.4.5 Peacehealth Recent Development
11.5 Novadaq
11.5.1 Novadaq Company Details
11.5.2 Novadaq Business Overview
11.5.3 Novadaq Lower GI Series Introduction
11.5.4 Novadaq Revenue in Lower GI Series Business (2016-2021)
11.5.5 Novadaq Recent Development
11.6 Astrazeneca
11.6.1 Astrazeneca Company Details
11.6.2 Astrazeneca Business Overview
11.6.3 Astrazeneca Lower GI Series Introduction
11.6.4 Astrazeneca Revenue in Lower GI Series Business (2016-2021)
11.6.5 Astrazeneca Recent Development
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Details
11.7.2 Ironwood Pharmaceuticals Business Overview
11.7.3 Ironwood Pharmaceuticals Lower GI Series Introduction
11.7.4 Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2016-2021)
11.7.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Lower GI Series Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Double-Contrast
Table 3. Key Players of Single-Contrast
Table 4. Global Lower GI Series Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Lower GI Series Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lower GI Series Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Lower GI Series Market Share by Regions (2016-2021)
Table 8. Global Lower GI Series Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Lower GI Series Market Share by Regions (2022-2027)
Table 10. Lower GI Series Market Trends
Table 11. Lower GI Series Market Drivers
Table 12. Lower GI Series Market Challenges
Table 13. Lower GI Series Market Restraints
Table 14. Global Lower GI Series Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Lower GI Series Market Share by Players (2016-2021)
Table 16. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower GI Series as of 2020)
Table 17. Ranking of Global Top Lower GI Series Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Lower GI Series Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lower GI Series Product Solution and Service
Table 21. Date of Enter into Lower GI Series Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lower GI Series Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Lower GI Series Revenue Market Share by Type (2016-2021)
Table 25. Global Lower GI Series Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Lower GI Series Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Lower GI Series Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Lower GI Series Revenue Market Share by Application (2016-2021)
Table 29. Global Lower GI Series Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Lower GI Series Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Lower GI Series Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Lower GI Series Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Lower GI Series Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Lower GI Series Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Lower GI Series Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Lower GI Series Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Lower GI Series Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Lower GI Series Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Lower GI Series Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Lower GI Series Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Lower GI Series Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Lower GI Series Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Lower GI Series Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Lower GI Series Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lower GI Series Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lower GI Series Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lower GI Series Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Lower GI Series Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Lower GI Series Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Lower GI Series Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Lower GI Series Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Lower GI Series Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Lower GI Series Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Lower GI Series Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Lower GI Series Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Lower GI Series Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lower GI Series Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lower GI Series Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lower GI Series Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Lower GI Series Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eisai Company Details
Table 62. Eisai Business Overview
Table 63. Eisai Lower GI Series Product
Table 64. Eisai Revenue in Lower GI Series Business (2016-2021) & (US$ Million)
Table 65. Eisai Recent Development
Table 66. Cadila Pharmaceuticals Company Details
Table 67. Cadila Pharmaceuticals Business Overview
Table 68. Cadila Pharmaceuticals Lower GI Series Product
Table 69. Cadila Pharmaceuticals Revenue in Lower GI Series Business (2016-2021) & (US$ Million)
Table 70. Cadila Pharmaceuticals Recent Development
Table 71. Purdue Pharma Company Details
Table 72. Purdue Pharma Business Overview
Table 73. Purdue Pharma Lower GI Series Product
Table 74. Purdue Pharma Revenue in Lower GI Series Business (2016-2021) & (US$ Million)
Table 75. Purdue Pharma Recent Development
Table 76. Peacehealth Company Details
Table 77. Peacehealth Business Overview
Table 78. Peacehealth Lower GI Series Product
Table 79. Peacehealth Revenue in Lower GI Series Business (2016-2021) & (US$ Million)
Table 80. Peacehealth Recent Development
Table 81. Novadaq Company Details
Table 82. Novadaq Business Overview
Table 83. Novadaq Lower GI Series Product
Table 84. Novadaq Revenue in Lower GI Series Business (2016-2021) & (US$ Million)
Table 85. Novadaq Recent Development
Table 86. Astrazeneca Company Details
Table 87. Astrazeneca Business Overview
Table 88. Astrazeneca Lower GI Series Product
Table 89. Astrazeneca Revenue in Lower GI Series Business (2016-2021) & (US$ Million)
Table 90. Astrazeneca Recent Development
Table 91. Ironwood Pharmaceuticals Company Details
Table 92. Ironwood Pharmaceuticals Business Overview
Table 93. Ironwood Pharmaceuticals Lower GI Series Product
Table 94. Ironwood Pharmaceuticals Revenue in Lower GI Series Business (2016-2021) & (US$ Million)
Table 95. Ironwood Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lower GI Series Market Share by Type: 2020 VS 2027
Figure 2. Double-Contrast Features
Figure 3. Single-Contrast Features
Figure 4. Global Lower GI Series Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Lower GI Series Report Years Considered
Figure 9. Global Lower GI Series Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Lower GI Series Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Lower GI Series Market Share by Regions: 2020 VS 2027
Figure 12. Global Lower GI Series Market Share by Regions (2022-2027)
Figure 13. Global Lower GI Series Market Share by Players in 2020
Figure 14. Global Top Lower GI Series Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lower GI Series as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Lower GI Series Revenue in 2020
Figure 16. Global Lower GI Series Revenue Market Share by Type (2016-2021)
Figure 17. Global Lower GI Series Revenue Market Share by Type (2022-2027)
Figure 18. North America Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Lower GI Series Market Share by Type (2016-2027)
Figure 20. North America Lower GI Series Market Share by Application (2016-2027)
Figure 21. North America Lower GI Series Market Share by Country (2016-2027)
Figure 22. United States Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Lower GI Series Market Share by Type (2016-2027)
Figure 26. Europe Lower GI Series Market Share by Application (2016-2027)
Figure 27. Europe Lower GI Series Market Share by Country (2016-2027)
Figure 28. Germany Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Lower GI Series Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Lower GI Series Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Lower GI Series Market Share by Region (2016-2027)
Figure 38. China Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Lower GI Series Market Share by Type (2016-2027)
Figure 46. Latin America Lower GI Series Market Share by Application (2016-2027)
Figure 47. Latin America Lower GI Series Market Share by Country (2016-2027)
Figure 48. Mexico Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Lower GI Series Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Lower GI Series Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Lower GI Series Market Share by Country (2016-2027)
Figure 54. Turkey Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Lower GI Series Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Eisai Revenue Growth Rate in Lower GI Series Business (2016-2021)
Figure 58. Cadila Pharmaceuticals Revenue Growth Rate in Lower GI Series Business (2016-2021)
Figure 59. Purdue Pharma Revenue Growth Rate in Lower GI Series Business (2016-2021)
Figure 60. Peacehealth Revenue Growth Rate in Lower GI Series Business (2016-2021)
Figure 61. Novadaq Revenue Growth Rate in Lower GI Series Business (2016-2021)
Figure 62. Astrazeneca Revenue Growth Rate in Lower GI Series Business (2016-2021)
Figure 63. Ironwood Pharmaceuticals Revenue Growth Rate in Lower GI Series Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Eisai Cadila Pharmaceuticals Purdue Pharma Peacehealth Novadaq Astrazeneca Ironwood Pharmaceuticals
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolle ... Read More
Malabsorption syndrome refers to a number of disorders in which the small intestine can’t absor ... Read More
Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have t ... Read More
Managed Pressure Drilling (MPD) is defined by the International Association of Drilling Contracto ... Read More